加载中
x
本网站使用必要的 cookie。经您同意,我们会放置 Google Analytics cookie 进行统计。

Cookie 政策 Slzii.com

这是 Cookie 政策 Slzii.com, accessible from slzii.com

What Are Cookies

As is common practice with almost all professional websites this site uses cookies, which are tiny files that are downloaded to your computer, to improve your experience. This page describes what information they gather, how we use it and why we sometimes need to store these cookies. We will also share how you can prevent these cookies from being stored however this may downgrade or 'break' certain elements of the sites functionality.

How We Use Cookies

We use cookies for a variety of reasons detailed below. Unfortunately in most cases there are no industry standard options for disabling cookies without completely disabling the functionality and features they add to this site. It is recommended that you leave on all cookies if you are not sure whether you need them or not in case they are used to provide a service that you use.

Disabling Cookies

You can prevent the setting of cookies by adjusting the settings on your browser (see your browser Help for how to do this). Be aware that disabling cookies will affect the functionality of this and many other websites that you visit. Disabling cookies will usually result in also disabling certain functionality and features of the this site. Therefore it is recommended that you do not disable cookies. This Cookies Policy was created with the help of the Cookies Policy Generator.

The Cookies We Set

  • Account related cookies

    If you create an account with us then we will use cookies for the management of the signup process and general administration. These cookies will usually be deleted when you log out however in some cases they may remain afterwards to remember your site preferences when logged out.

  • Login related cookies

    We use cookies when you are logged in so that we can remember this fact. This prevents you from having to log in every single time you visit a new page. These cookies are typically removed or cleared when you log out to ensure that you can only access restricted features and areas when logged in.

  • Site preferences cookies

    In order to provide you with a great experience on this site we provide the functionality to set your preferences for how this site runs when you use it. In order to remember your preferences we need to set cookies so that this information can be called whenever you interact with a page is affected by your preferences.

Third Party Cookies

In some special cases we also use cookies provided by trusted third parties. The following section details which third party cookies you might encounter through this site.

  • This site uses Google Analytics which is one of the most widespread and trusted analytics solution on the web for helping us to understand how you use the site and ways that we can improve your experience. These cookies may track things such as how long you spend on the site and the pages that you visit so we can continue to produce engaging content.

    For more information on Google Analytics cookies, see the official Google Analytics page.

  • Third party analytics are used to track and measure usage of this site so that we can continue to produce engaging content. These cookies may track things such as how long you spend on the site or pages you visit which helps us to understand how we can improve the site for you.

  • From time to time we test new features and make subtle changes to the way that the site is delivered. When we are still testing new features these cookies may be used to ensure that you receive a consistent experience whilst on the site whilst ensuring we understand which optimisations our users appreciate the most.

  • We also use social media buttons and/or plugins on this site that allow you to connect with your social network in various ways. For these to work the following social media sites including; {List the social networks whose features you have integrated with your site?:12}, will set cookies through our site which may be used to enhance your profile on their site or contribute to the data they hold for various purposes outlined in their respective privacy policies.

More Information

Hopefully that has clarified things for you and as was previously mentioned if there is something that you aren't sure whether you need or not it's usually safer to leave cookies enabled in case it does interact with one of the features you use on our site.

For more general information on cookies, please read the Cookies Policy article.

However if you are still looking for more information then you can contact us through one of our preferred contact methods:

  • By visiting this link: https://www.slzii.com/contact

搜索 (消息)

荷兰 | 比利时 | 库拉索 | 泰国 | 尼日利亚 | 德国 | 西班牙 | 墨西哥 | 哥伦比亚 | 委内瑞拉 | 阿根廷 | 乌拉圭 | 智利 | 厄瓜多尔 | 波多黎各 | 秘鲁 | 古巴 | 玻利维亚 | 哥斯达黎加 | 多明尼加共和国 | 萨尔瓦多 | 危地马拉 | 洪都拉斯 | 尼加拉瓜 | 巴拉圭 | 巴拿马 | 法国 | 象牙海岸 | 摩纳哥 | 喀麦隆 | 刚果共和国 | 加蓬 | 塞内加尔 | 贝宁 | 埃及 | 阿拉伯联合酋长国 | 卡塔尔 | 沙特阿拉伯 | 摩洛哥 | 伊拉克 | 突尼斯 | 苏丹 | 也门 | 巴林 | 伊朗 | 巴西 | 葡萄牙 | 冰岛 | 挪威 | 中国 | 台湾 | 香港 | 澳门 | 以色列 | 尼泊尔 | 捷克共和国 | 波兰 | 意大利 | 孟加拉国 | 越南 | 火鸡 | 马来西亚 | 文莱 | 韩国 | 北朝鲜 | 印度尼西亚 | 日本 | 印度 | 俄罗斯 | 菲律宾 | 乌克兰 | 瑞士 | 芬兰 | 卢森堡 | 爱尔兰 | 爱沙尼亚 | 罗马尼亚 | 保加利亚 | 美国 | 肯尼亚 | 塞浦路斯 | 希腊 | 列支敦士登 | 乌干达 | 瑞典 | 大不列颠 | 尼日尔 | 巴基斯坦 | 蒙古 | 巴勒斯坦 | 亚美尼亚 | 奥地利 | 澳大利亚 | 加拿大 | 丹麦 | 阿尔及利亚 | 加纳 | 克罗地亚 | 匈牙利 | 柬埔寨 | 斯里兰卡 | 立陶宛 | 拉脱维亚 | 马耳他 | 新西兰 | 塞舌尔 | 新加坡 | 斯洛伐克 | 南非 | 安道尔 | 赞比亚 | 毛里求斯 | 坦桑尼亚 | 英属维尔京群岛 | 多哥 | 阿塞拜疆 | 摩尔多瓦 | 斯洛文尼亚 | 伯利兹 | 哈萨克斯坦 | 吉尔吉斯斯坦 | 塞尔维亚 | 乌兹别克斯坦 | 白俄罗斯 | 几内亚 | 乔治亚州 | 波斯尼亚和黑塞哥维那 | 约旦 | 科威特 | 科索沃 | 阿尔巴尼亚 | 莫桑比克 | 阿富汗 | 塔吉克斯坦 | 黑山 | 利比亚 | 刚果-金沙萨 | 黎巴嫩 | 津巴布韦 | 叙利亚 | 马里 | 不丹 | 赤道几内亚 | 卢旺达 | 马拉维 | 缅甸 | 博茨瓦纳 | 北马其顿 | 布隆迪 | 牙买加 | 埃塞俄比亚 | 新喀里多尼亚 | 塞拉利昂 | 纳米比亚 | 老挝 | 东帝汶 | 马尔代夫 | 海地 | 布基纳法索 | 阿曼 | 巴哈马 | 索马里 | 巴巴多斯 | 格林纳达 | 巴布亚新几内亚 | 球衣 | 斐济 | 圣马力诺 | 法属波利尼西亚 | 特立尼达和多巴哥 | 苏里南 | 莱索托 | 厄立特里亚 | 圣卢西亚 | 开曼群岛 | 安哥拉 | 冈比亚 | 斯威士兰 | 马达加斯加 | 利比里亚 | 毛里塔尼亚 | 圭亚那 | 瓦努阿图 | 乍得 | 汤加 | 百慕大 | 土库曼斯坦 | 萨摩亚 | 吉布提 | 科摩罗 | 梵蒂冈城 | 帕劳 | 多米尼加 | 佛得角 | 中非共和国 | 所罗门群岛 | 图瓦卢 | Sint Maarten |
genOway: Revolutionizing the Prediction of Antibody Therapies in Humans with Unique Mouse Model
LYON, France, Feb. 26, 2026 /PRNewswire/ -- Antibody therapies are changing the treatment of cancer, inflammatory diseases and infections. However, many promising drug candidates fail in clinical trials. A study in Science Immunology shows that genOway's genO-hFcγR mouse model enables more accurate prediction of therapeutic antibody efficacy and safety. genOway: Revolutionizing the Prediction of Antibody Therapies in Humans with Unique Mouse Model Why Antibody Therapies Fail in Late-Stage Testing Antibody therapies work in part by binding to Fcγ receptors, proteins found on immune cells that control key immune functions such as antibody-mediated cell killing and inflammation. Since these receptors are different between species, human therapies tested in standard laboratory mice give unreliable efficacy results or miss potential safety risks. These discrepancies cause expensive late-stage failures and slow patient access to new therapies. A New Mouse Model with Humanized Fcγ Receptors Set to Become a Gamechanger A new study published in Science Immunology showed that an innovative mouse model developed by genOway, genO-hFcγR, helps scientists better predict the efficacy and safety of therapeutic antibodies in humans. The model allows scientists to rank different antibody candidates by how they are likely to perform, measure how effectively they target specific immune cells, and evaluate their potential to slow disease progression. This gives researchers key early insights to guide decisions and accelerate drug development. Video on genO-hFcγR mice: https://www.youtube.com/watch?v=H7xO-xGJV8Q Read the publication: https://www.science.org/doi/10.1126/sciimmunol.ady7328 A Complex Scientific Challenge Achieved Through International Collaboration Due to the species-specific nature of Fcγ receptors, developing this model demanded multidisciplinary expertise in mouse genetics, antibody biology, and human immunology. The achievement was made possible through an international consortium of leading biopharmaceutical partners, led by genOway, who combined their knowledge to co-develop and co-validate the genO-hFcγR mouse model. Consortium members included genOway (France), a company specializing in developing highly predictive preclinical models; argenx (Belgium), a pioneer in Fc-engineering and FcRn biology; Innate Pharma (France), a leader in natural killer cell-based immunotherapies; and Vir Biotechnology (USA), focused on the development of immunotherapies; among other members. The group collaborated with VIB-Ghent University (Belgium), a leading immunology institute, to publish the study in Science Immunology. In this study, scientists at VIB-Ghent University mapped Fc receptor expression and regulation to illustrate how the new mouse model could be used to better model human disease and coordinated the publication of the work. A Unique Solution Available for the Scientific Community The genO–hFcγR model builds on a previous mouse model developed in 2008 by genOway and its scientific partners, in which multiple FcγR genes were humanized. Since its launch to the scientific community in 2024, genO-hFcγR has been adopted to advance preclinical programs of biopharmaceutical companies and nonprofit organizations, including the Gates Foundation, as one of the foundation's global health research initiatives. Read the Gates Foundation press release at https://www.genoway.com/news-events/genoway-gates-foundation-2025 About genOwaygenOway is a biotechnology company that provides highly predictive preclinical models and solutions to biopharmaceutical companies, CROs and academic institutions to bridge the gap between preclinical findings and clinical success. More information at genoway.com. ContactAna REZA Marketing Communications Manager reza@genoway.com genOway: Revolutionizing the Prediction of Antibody Therapies in Humans with Unique Mouse Model
2026-02-26 08:15:00

World Gym Corporation Reports Full-Year 2025 Financial Results
Net Profit of NT$409.1 Million (US$12.8 million), Up 16.3%; Q4 EPS Reaches NT$1.53; Board Approves NT$4.11 per Share Q4 Dividend TAIPEI, Feb. 26, 2026 /PRNewswire/ -- World Gym Corporation (2762.TW) ("World Gym" or the "Company"), the owner of the iconic World Gym brand with over 280 locations worldwide, announced its full-year 2025 financial results on February 24th. The company achieved solid profitability growth, driven by higher revenue and improved operating margins, with particularly strong performance in the fourth quarter. Key Financial Highlights Full-Year 2025 Net Profit: NT$409.1 million (US$12.8 million) — up 16.3% compared to 2024 Q4 2025 Net Profit: NT$166.9 million (US$5.2 million) — up 175.8% year-over-year (YoY) Q4 2025 Earnings Per Share (EPS): NT$1.53 Compared to NT$1.04 in Q3 2025 Compared to NT$0.55 in Q4 2024 Dividend Approval: Q4 2025 dividend: NT$4.11 per share (to be distributed on April 2nd) The results highlight momentum in membership fees, personal training, franchising, and operational efficiencies across the network. The consistent quarter-on-quarter EPS improvement, culminating in Q4 EPS of NT$1.53, reflects sustained revenue growth and meaningful margin expansion throughout 2025. The Board-approved Q4 dividend of NT$4.11 per share brings the total cash dividend for full-year 2025 to NT$5.95 per share. This distribution underscores the Company's strong store-level cash flow generation and robust financial position, enabling it to reward shareholders while continuing to invest in network expansion, service innovation, and international opportunities. "2025 was a transformative year for World Gym Corporation, with exceptional Q4 results capping off solid full-year growth," said John Caraccio, President of World Gym Corporation. "Our focus on high-margin services, operational excellence, and strategic global expansion has driven meaningful profitability gains. We remain confident in our momentum heading into 2026 as we continue to strengthen our position in Taiwan and internationally." Looking ahead to 2026, World Gym Corporation is poised for continued acceleration with ambitious growth initiatives. The Company plans to add 12-15 new corporate-owned locations, targeting high-potential sites that contribute immediately to profitability. To drive same-store sales growth at existing fitness centers, World Gym will introduce innovative products and services, including specialized Pilates programs in one-on-one and small-group formats across its network, as well as an AI-driven health management platform that delivers personalized wellness insights, data tracking, and enhanced member experiences through integrated digital tools. Note: Based on a USD/TWD exchange rate of 31.18 Item 2025 Q4 2025 Q3 QoQ% 2024 Q4 YoY% Operating Revenues 2,878,482 2,823,808 1.94 2,541,528 13.26 Gross Profit 598,142 471,877 26.76 392,248 52.49 Income before tax 214,776 138,660 54.89 74,414 188.62 Net Income 166,896 113,177 47.46 60,513 175.80 Unit: Thousands of NTD About World Gym Corporation World Gym Corporation is Taiwan's largest fitness chain, operating 139 locations. In 2024, it acquired World Gym International, securing the iconic World Gym brand and global operating rights, establishing itself as a global fitness leader. With a franchise network spanning 10 countries and 284 locations, it serves 900,000 members. The company continues to empower individuals worldwide to achieve their fitness goals and live healthier lives through state-of-the-art facilities, innovative programs, and technology-driven solutions.
2026-02-26 08:12:00

Changingtek Robotics Launches the World's First Adaptive "X2" Left-Right Dexterous Hand
SUZHOU, China, Feb. 26, 2026 /PRNewswire/ -- As a global leader in robotic end-effector solutions, Changingtek Robotics Technology (Suzhou) Co., Ltd. proudly unveils the world's first adaptive "X2" — left-right dexterous hand (LRD Hand). Powered by an innovative tendon-driven transmission system, X2 enables autonomous reconstruction between left-hand and right-hand configurations. This breakthrough achieves significant advancements in lightweight design, operational flexibility, and functional freedom, redefining performance standards for robotic dexterous hands. X2 offers multiple core performance advantages. Each of its five fingers is independently controlled, allowing coordinated execution of complex manipulation tasks. Despite its lightweight structure, it achieves a maximum gripping force of 50 N per hand and up to 10 N fingertip force per finger, with a force control accuracy of ±0.1 N, balancing heavy-load handling with precision-level operations. Its rich degrees of freedom enable high-difficulty tasks such as insertion, extraction, and assembly in narrow or complex environments. Integrated with a proprietary high-precision vision coordination system, X2 supports object recognition, positioning, and adaptive grasping, ensuring efficient deployment and flexible operation across dynamic applications. X2 is widely applicable in aerospace, intelligent manufacturing, laboratory automation, and service robotics. By enhancing equipment utilization and environmental adaptability, it empowers industries with more flexible and intelligent automation solutions. Changingtek Robotics focuses on the R&D, manufacturing, and integration of solutions of dexterous hands, robotic end effectors, and embodied intelligent robots. The company has established three core technology platforms: mechanical intelligence, perception intelligence, and drive-control intelligence. Its comprehensive "Changingtek Hand" product portfolio spans industrial parallel hands, collaborative hands, dexterous hands, and heavy-duty hands, covering payload capacities from a few grams to several hundred kilograms — meeting full-scenario requirements from precision assembly to heavy material handling. Leveraging tactile-visual fusion and AI-powered intelligent control technologies, Changingtek Robotics delivers stable and efficient intelligent gripping solutions for aerospace, automotive manufacturing, smart logistics, and beyond. By addressing industry challenges such as high application costs, limited flexibility, and complex deployment, the company continues to drive innovation and large-scale adoption of robotic end-effector technologies worldwide. For more information, please click: https://youtu.be/Ay3KCk7ZuWE Contact information: Changingtek Robotics Technology (Suzhou) Co., Ltd. Tel: +86 512 5323 3370 / +86 158 7124 2390WhatsApp: +86 158 7124 2390Email: support@ctek.ltd / hannah@ctek.ltdWeb: www.changingtek.comAddress: Building 18, Zhihuigu Science and Technology Innovation Park, No. 99, Fuda Road, Taicang City, Jiangsu Province, China
2026-02-26 08:11:00

Sgcarmart Announces "Beyond Motion" Singapore's First Immersive Mobility Experience on March 21-22, 2026, Featuring Leading EV Brands, Industry Experts, and Future Forward Talks
SINGAPORE, Feb. 26, 2026 /PRNewswire/ -- Sgcarmart, Singapore's most trusted automotive platform, is launching Beyond Motion, its first ever experience-driven electrified mobility showcase, taking place on March 21–22, 2026 at the Suntec Convention Centre, Halls 403–404. Designed for prospective EV buyers, car enthusiasts, industry professionals, and anyone curious about the future of electric mobility, Beyond Motion will bring together major brands, experts, and ecosystem partners for two days of discovery, education, and hands-on engagement. Beyond Motion by Sgcarmart Event Poster Singapore's EV adoption has accelerated rapidly, with 2025 marking the first year that fully electric vehicles became the top choice among new passenger car registrations, representing 45% of the market. "Electrification, new energy, digitalisation, shifting consumer expectations and global competition are accelerating the transformation of how people and goods move." said Shahrul Tahir, CEO of Sgcarmart. "Beyond Motion creates the ideal environment for consumers and industry stakeholders to explore the electrified future together." A First of Its Kind EV Experience for All Over two days, Beyond Motion will offer an interactive, accessible, and highly engaging programme designed to simplify EV adoption and introduce attendees to the latest advancements in electrified mobility: Multi Brand EV Showcase Brand EV Showcase Visitors can explore, compare, and experience the latest electric and hybrid models under one roof. With over eight exhibiting brands, attendees can expect new model launches, technology showcases, and event exclusive promotions. Education Hubs and Learning Zones Expert led sessions will cover EV ownership fundamentals, charging infrastructure, battery innovation, sustainability, and future mobility trends. Specialists will be available to address practical questions on daily usage, charging routines, and lifestyle considerations. Industry Conversations & Expert Panels Beyond Motion will host policymakers, charging providers, OEMs, and mobility innovators for panel discussions, keynote conversations, and moderated sessions. These dialogues will explore Singapore's electrification roadmap, infrastructure development, technology shifts, and opportunities for collaboration across the mobility ecosystem. Interactive Experiences and Prizes Attendees can participate in hands on activities, discover new technologies, and complete a stamp rally to redeem event exclusive prizes, making the experience engaging for first time EV explorers and experienced industry professionals alike "Through immersive and interactive experiences, we hope to bridge the gap for those considering the transition to electric mobility, while helping shape how the wider ecosystem continues to evolve," said Yau Fun Heng, COO of Sgcarmart. Registration Now Open Admission to Beyond Motion is free with registration. Members of the public are encouraged to register early to secure access to sessions, activities, and prize opportunities. Event Details Event: Beyond Motion Dates: 21–22 March 2026 Venue: Suntec Convention Centre, Halls 403–404 Admission: Free with registration About Sgcarmart Sgcarmart is Singapore's No. 1 car platform. With over 30,000 listings, it hosts the largest database of new and used cars, supporting approximately 70% of all second-hand car transactions in Singapore. The platform receives more than 1.6 million users every month and provides a comprehensive suite of value-added car ownership and transactional services.
2026-02-26 08:10:00

GAC's Innovative Safety and High-Efficiency Powertrain Win Global Recognition
GUANGZHOU, China, Feb. 13, 2026 /PRNewswire/ -- The global automotive industry is undergoing rapid transformation. At GAC, technological innovation remains at the core of our mission to deliver safer, more efficient, and more reliable mobility experiences for users worldwide. With proprietary core technologies, GAC is accelerating its global footprint and earning trust through quality—trust built on an unwavering commitment to high standards, high requirements, and high quality. High safety standards are fundamental to our approach. The Magazine Battery represents comprehensive innovation from cell to system. During R&D, GAC subjected the technology to tests far exceeding industry norms and proactively meeting future national standards. Under extreme conditions such as needle penetration, crushing, and twisting, the Magazine Battery does not ignite or explode, mitigating risks at the source. It is this commitment to high standards that transforms technology into a solid foundation of user trust. GAC applies high requirements throughout the entire vehicle usage cycle. The "GAC X-SOUL Safety Protection System" extends safety across the full lifecycle, enabling early risk identification, intelligent stability control for hazard avoidance—all rigorously validated to standards far exceeding industry benchmarks, from 24/7 monitoring to dual-redundancy backups for key systems. With risks "rehearsed" in advance, round-the-clock protection ensures peace of mind on every journey. Technological innovation delivers high-quality outcomes. The Quark Electric Drive 2.0, named one of the "World's Top 10 Electric Drive Systems," features lightweight construction and high efficiency, delivering powerful performance while reducing energy consumption and enhancing range and responsiveness. The third-generation hybrid technology, also recognized among the "World's Top 10 Hybrid Systems," achieves an optimal balance between power and fuel economy through high integration, offering a quiet, smooth, and premium driving experience. These are high-quality breakthroughs in efficiency, performance, and reliability. From battery safety to intelligent protection, from electric drive efficiency to hybrid driving experience, GAC is redefining the quality benchmark for new energy vehicles with a portfolio of internationally recognized core technologies. As we expand into global markets, GAC will continue to uphold high standards, high requirements, and high quality—bringing China's innovation power and craftsmanship to more users around the world. For further information about GAC, please visit: https://www.gacgroup.com/en or follow us on social.
2026-02-13 14:18:00

Novel Anti-Fibrotic Drug AK3280 Cleared by FDA to Initiate Phase 2 Proof-of-Concept Clinical Trial in IPF
SHANGHAI, Feb. 12, 2026 /PRNewswire/ -- Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio") today announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for AK3280, a novel anti-fibrotic therapy for the treatment of idiopathic pulmonary fibrosis (IPF). This clearance enables ArkBio to initiate a Phase 2 proof-of-concept (PoC) clinical trial of AK3280 in the United States. The Phase 2 study is a multi-center, randomized, partially double-blind, placebo- and active-controlled trial designed to evaluate the efficacy, safety, and pharmacokinetics of oral AK3280 in patients with IPF. Authorization to proceed with a U.S. Phase 2 study represents a significant milestone in the global clinical development of AK3280. IPF is a progressive, irreversible, and ultimately fatal interstitial lung disease characterized by fibrotic remodeling of lung tissue that leads to respiratory failure. The median survival following diagnosis is approximately 2–5 years. Currently approved therapies, including pirfenidone, nintedanib, and nerandomilast, can slow disease progression; however, their clinical benefit remains limited and they are frequently associated with gastrointestinal adverse events such as diarrhea and nausea. These tolerability challenges contribute to poor long-term adherence in a substantial proportion of patients. There remains a significant unmet need for therapies that provide improved efficacy with enhanced safety and tolerability profiles. AK3280 is an optimized, small-molecule, broad-spectrum anti-fibrotic agent. In a Phase 2 proof-of-concept study conducted in China, AK3280 demonstrated encouraging clinical activity, including a statistically significant, dose-dependent absolute increase from baseline in forced vital capacity (FVC) at Week 24. Improvements were also observed across additional lung function parameters, suggesting meaningful clinical benefit. Importantly, AK3280 exhibited a favorable safety and tolerability profile, with no apparent increase in the gastrointestinal adverse effects commonly associated with currently available IPF therapies. FDA clearance of the IND marks a pivotal step in the global development of AK3280. The upcoming international Phase 2 PoC trial is expected to generate critical clinical data to support future regulatory submissions and potential commercialization in the United States and other major markets. ArkBio remains committed to advancing AK3280 globally and to delivering more effective and better-tolerated treatment options for patients living with IPF. About ArkBio ArkBio is a commercial-stage biotechnology company focused on the discovery and development of innovative therapeutics for respiratory and pediatric diseases. Founded in 2014, the company has established proprietary technology platforms and a differentiated R&D pipeline through internal innovation and strategic collaborations. Key pipeline assets include: Ziresovir (AK0529), the first direct-acting antiviral for RSV with positive pivotal Phase 3 results; AK3280, a potentially best-in-class anti-fibrotic agent with positive Phase 2 results in idiopathic pulmonary fibrosis; AK0901, approved in China for the treatment of ADHD and currently commercialized. ArkBio has established strategic partnerships with multinational pharmaceutical companies and leading academic institutions, including Roche, Genentech, The Scripps Research Institute, and the Institute of Microbiology of the Chinese Academy of Sciences, as well as domestic and international biotech companies and venture capital partners. For more information, please visit: www.arkbiosciences.comInvestor Inquiries: IR@arkbiosciences.com
2026-02-12 04:18:00

Dreame Wet Dry Vacuum Makes Its U.S. Prime-Time Debut on Game Day with NBC
SAN FRANCISCO, Feb. 9, 2026 /PRNewswire/ -- On February 8, Dreame Wet Dry Vacuum announced a high-profile collaboration with NBC, one of the three major U.S. broadcast television networks, securing its debut on U.S. national prime-time television. The brand's 30-second commercial will air on Game Day, during Championship Sunday coverage, placing Dreame wet dry vacuum on one of the most-watched live broadcast stages in the United States and reaching tens of millions of viewers nationwide through NBC's broadcast and affiliate network. Dreame Wet Dry Vacuum For Dreame, the campaign represents a key step in introducing its wet dry vacuum category to the American mainstream. By appearing during a premium live sports broadcast, the technology-driven brand is showcasing how intelligent cleaning innovation can deliver a more efficient approach to everyday floor care. The commercial features Aero Pro, one of Dreame's latest wet & dry vacuum models introduced to the U.S. market following its debut at CES 2026. Designed as an all-in-one solution, Aero Pro vacuums and mops in a single pass, handling both wet spills and dry debris. Its ultra-slim 3.88-inch profile and 180-degree lie-flat design enable easy cleaning under sofas and beds, while a dual-scraper system helps reduce hair tangling and maintain streak-free results. During CES, NBA legend and youngest MVP in league history Derrick Rose experienced Aero Pro firsthand, highlighting its cleaning performance and sleek design. Beyond broadcast exposure, Dreame continues to deepen its presence in the U.S. innovation ecosystem. Following CES, the brand hosted its global innovation launch event, "The Future of Smart Living," at Stanford University in Silicon Valley, where it showcased its latest advancements in intelligent cleaning technology alongside initiatives supporting children's health and well-being. Today, Dreame operates in more than 120 countries and regions worldwide. Dreame wet dry vacuum holds the No.1 market share in 17 countries, and has filed over 1,700 global patent applications. As the brand expands its global footprint, it remains focused on translating advanced technology into practical solutions for everyday cleaning scenarios. To coincide with the Game Day campaign, Dreame is offering a limited-time promotion for U.S. consumers. Consumers can receive a discount by using the code GAMEDAY10 on Dreame's U.S. website between February 1 and February 28, with availability subject to terms and exclusions. About Dreame Technology Established in 2017, Dreame Technology is a global leader in high-end consumer electronics and intelligent manufacturing with the vision to empower lives through technology. Follow us on Facebook, Instagram, TikTok and Twitter. For more information, please visit https://www.dreametech.com/.
2026-02-09 08:29:00

البرنامج السعودي يطلق مبادرة تعزيز استقرار التعليم بمحافظة سقطرى
سقطرى - سبأنت أطلق البرنامج السعودي لتنمية وإعمار اليمن، مبادرة تعزيز استقرار التعليم في جزيرة سقطرى، وذلك في إطار الجهود التنموية السعودية المقدمة دعمًا لقطاع التعليم في اليمن. وأثمرت المبادرة في استئناف العملية التعليمية في جامعة سقطرى وإعادة فتح أبوابها، وذلك بالتعاون مع وزارة التعليم العالي والبحث العلمي. ويدعم البرنامج السعودي لتنمية وإعمار اليمن قطاع التعليم بمختلف مستوياته، وقدم دعمه في 11 محافظة يمنية وهي: تعز، عدن، سقطرى، المهرة، مأرب، حضرموت، حجة، لحج، أبين، شبوة، الضالع، عبر تنفيذ نحو 60 مشروعًا ومبادرة تنموية مستدامة. وتشمل المشاريع والمبادرات التعليمية دعم التعليم العام والعالي والتدريب الفني والمهني، والتي جاءت للمساهمة في تحقيق تأثير إيجابي في حياة الأفراد والمجتمعات المحلية في اليمن، والمساهمة في تعزيز التنمية الشاملة وبناء مستقبل مُشرق وواعد في اليمن.
2026-02-06 11:43:43

Avnet Insights Survey: APAC Engineers Accelerate AI Adoption Across Industries
China Masters AI at Scale, Japan Leads in Reliability, Driving Regional Innovation SINGAPORE, Feb. 5, 2026 /PRNewswire/ -- Artificial intelligence (AI) is increasingly embedded in products and solutions across Asia-Pacific, as engineers advance adoption while addressing operational and design challenges. This is according to Avnet's fifth annual Avnet Insights survey, which tracks global trends in AI integration across industries. Globally, 77% of engineers reported improving market conditions for their design products and solutions. Across APAC, adoption is accelerating, with China leading in large-scale deployment and Japan emphasizing reliability and long product lifecycles. These regional strengths and shifting priorities are collectively fueling the next wave of Asia-Pacific's technological evolution. "While the survey focuses on major global design hubs, the findings serve as a critical framework for Southeast Asian markets," said Tan Aik Hoon, Regional President for Avnet South Asia, Korea and Avnet United. "As ASEAN grows as a global manufacturing powerhouse, the 'commercial-first' AI strategies highlighted in the report offer a clear path forward for engineers in Singapore, Malaysia, and Vietnam looking to maintain competitive speeds." Download the 2026 Avnet Insights: The Reality of Artificial Intelligence whitepaper here. How is AI Adoption Advancing Across APAC?More than half of engineers globally (56%) said they are shipping products with AI incorporated, a 33% increase from the previous year. In China, adoption exceeds the global average, with engineers embedding AI across industries including automotive, industrial automation, and smart manufacturing. Japan and other APAC markets are advancing steadily, prioritizing practical applications that enhance efficiency, reliability, and sustainability. Top AI applications across the region mirror global trends: process automation (42%), predictive maintenance (28%), and fault/anomaly detection (28%) remain the most adopted functionalities. Engineers are also increasingly combining Edge AI and machine learning (ML), with 64% globally prioritizing both equally, reflecting the growing importance of multi-modal AI. "We see a clear shift from AI experimentation to industrial-scale deployment across the ASEAN manufacturing corridor," added Tan. "Regional engineers face a growing complexity tax—balancing rapid time-to-market with specialized data requirements. Avnet's role is to help partners overcome these barriers and move from concept to revenue faster." Navigating Challenges to Drive Broadening ImpactAs AI's influence expands, APAC engineers continue to balance technical challenges with evolving skill requirements. Data quality (46%) and continuous maintenance (54%) remain the most cited obstacles, while regional teams are investing in talent development—particularly in model optimization (17%) and data analysis (16%)—to convert complexity into competitive advantage. "The report confirms that AI has entered its most critical phase: at-scale implementation," concluded Tan. "In a market where production speed drives optimism, Avnet helps bridge the regional resource gap by providing the technical expertise and ecosystem support our partners need to lead—not just participate—in Asia-Pacific's technological evolution." The 2026 Avnet Insights survey conducted online was fielded to 1,200 engineers from the Americas, EMEA, Asia and Japan, from October 21 through November 5, 2025. Download the full 2026 Avnet Insights: The Reality of Artificial Intelligence whitepaper here. About AvnetAs a leading global technology distributor and solutions provider, Avnet has served customers' evolving needs for more than a century. Through regional and specialized businesses around the world, we support customers and suppliers at every stage of the product lifecycle. We help companies adapt to change and accelerate the design and supply stages of product development. With a unique viewpoint from the center of the technology supply chain, Avnet is a trusted partner that solves complex design and supply chain issues so customers can realize revenue faster. Learn more about Avnet at www.avnet.com. CONTACT: Seraphina Wee, seraphina.wee@avnet.com
2026-02-05 02:00:00

Grand Copthorne Waterfront Hotel Singapore Honoured with ASEAN MICE Venue Award 2026
SINGAPORE, Feb. 4, 2026 /PRNewswire/ -- Grand Copthorne Waterfront Hotel Singapore has been awarded the ASEAN MICE Venue Award 2026 in the Meeting Room Category, a prestigious regional recognition under the ASEAN MICE Venue Standard (AMVS). The award celebrates venues that meet the highest benchmarks for business meetings across Southeast Asia and was officially presented at the ASEAN Tourism Standards Awards Ceremony during the ASEAN Tourism Forum (ATF) on 30 January 2026 in Cebu, Philippines. General Manager Andrew Tan receiving the award at the ASEAN Tourism Standards Awards Ceremony at the ASEAN Tourism Forum on 30 January 2026 In 2026, only 41 establishments across all ten ASEAN Member States attained this distinction after undergoing rigorous on-site audits evaluating structural quality, soundproofing, amenities, safety standards and service excellence. Grand Copthorne Waterfront is one of only two hotels in Singapore to receive the award, and one of just three Singapore representatives overall, highlighting its leadership in the regional MICE sector and reinforcing Singapore's standing as a premier MICE destination. The ASEAN MICE Venue Award – Meeting Room category honours venues that meet rigorous standards in facilities, service, safety and accessibility. This recognition reflects the hotel's commitment to quality and seamless meeting experiences. Commenting on the achievement, Andrew Tan, General Manager of Grand Copthorne Waterfront, said: "This ASEAN MICE Venue Award is a strong affirmation of our team's dedication to delivering exceptional meeting experiences. It reflects the high standards we uphold across our facilities, service and operations, and reinforces our commitment to continuously innovate and elevate the experience for our clients and partners." Benedict Ng, Vice President, Operations, Southeast Asia and North America, added:"Being recognised under the ASEAN MICE Venue Standard places Grand Copthorne Waterfront among the region's most trusted and capable MICE venues. This achievement highlights the strength of our operational excellence and our continued investment in people, infrastructure and technology to support world-class business events." The accolade follows the hotel's $40 million refurbishment completed at the end of 2023, which significantly enhanced its MICE capabilities. Featuring 6,200 square metres of meetings and events space, including naturally lit meeting rooms and three pillarless ballrooms spanning 1,385 square metres; the hotel is well equipped to support hybrid, in-person and virtual events. Overlooking the Singapore River, its venues offer a distinctive setting paired with state-of-the-art technology and world-class audio-visual facilities, reinforcing its role in elevating regional MICE standards and strengthening Singapore's position as a leading international MICE hub. Contact: Claire Chan, Assistant Director of Marketing CommunicationsClaire.Chan@millenniumhotels.com Kok Nee Tsu, Assistant Manager of Marketing Communicationsneetsu.kok@millenniumhotels.com
2026-02-05 01:17:00

Gallop into Radiant Journeys with The Shilla Duty Free this Lunar New Year
Enjoy Exclusive Disney Tsum Tsum Collectibles and Tax-Absorbed Shopping Privileges SINGAPORE, Feb. 2, 2026 /PRNewswire/ -- The Shilla Duty Free welcomes the Year of the Horse with a lineup of Lunar New Year travel retail initiatives, led by its exclusive partnership as the Official Beauty Travel Retail Partner of Mandopop artist Silence Wang's (汪苏泷) Singapore concerts, followed by the first collaboration with Disney's Tsum Tsum, and tax-absorbed shopping privileges on iShopChangi. The Shilla Duty Free at Changi Airport (Terminal 1) Running from 22 January to 8 March 2026, the Lunar New Year campaign will be available across all The Shilla Duty Free transit stores and iShopChangi, offering travellers exclusive collectibles, festive sure-win activations and extended online shopping convenience. Win Tickets to the Fully Sold out Silence Wang's (汪苏泷) Singapore Concerts The Shilla Duty Free is the Official Beauty Travel Retail Partner for Mandopop artist Silence Wang (汪苏泷) and his fully sold-out Singapore concerts, taking place from 27 to 29 March 2026. The Singapore shows mark the grand finale of his first world tour, Rise of Romance. During the Lunar New Year campaign period, shoppers at The Shilla Duty Free who spend a minimum in-store nett amount of S$250 stand a chance to win tickets to the sold-out concerts. Winners will be eligible to attend either the 28 or 29 March 2026 show, subject to availability and applicable terms and conditions. First-Ever Disney's Tsum Tsum Lunar New Year Collaboration For the first time, The Shilla Duty Free partners with Disney's Tsum Tsum to introduce a series of Lunar New Year exclusives created specifically for the travel retail market. A key highlight of the collaboration is the Tsum Tsum Zodiac Charm Phone Strap, featuring all 12 zodiac designs, including a special limited-edition Year of the Horse charm created exclusively for Lunar New Year 2026. Priced at S$9.90 per box, the blind boxes are available with any in-store purchase at The Shilla Duty Free main stores all four terminals, as well as on iShopChangi. In addition, shoppers can receive a limited-edition Tsum Tsum red packet set with a minimum in-store spend of S$188, while stocks last. During the Lunar New Year period, travellers across all the terminals can also participate in the Tsum Tsum "Ring of Fortune" Wheel Spin, a sure-win activation offering The Shilla Duty Free shopping vouchers. Shoppers may also scan to receive the digital Zodiac Luck Cards featuring Tsum Tsum-themed zodiac fortune predictions. Shop and Save with Tax-Absorbed Shopping on iShopChangi Travellers can continue their Lunar New Year shopping on iShopChangi with tax-absorbed beauty purchases by the Shilla Duty Free for up to 30 days before travel and after arrival, along with complimentary delivery on qualifying orders of S$59 and above, subject to participating merchants and product availability. In addition to standing a chance to win tickets to Silence Wang's fully sold-out Singapore concerts, travellers can further elevate their festive shopping experience with S$60 off their iShopChangi purchase when they spend a minimum of S$320 online, using the promotional code SILENCE60. The promotion is valid until 31 March 2026, subject to applicable terms and conditions. For more information on the latest promotions and updates, please visit The Shilla Duty Free Singapore's Instagram at https://www.instagram.com/shilladutyfreesg. Download high-resolution key visuals here. ABOUT THE SHILLA DUTY FREE Since its grand opening in 2015, The Shilla Duty Free Changi Airport Store today features up to 120 Cosmetic and Perfume brands in its stores. With more than 20 Cosmetics and Perfumes stores across the airport's four terminals, including Shilla Beauty Loft, the first-in-the-world luxury spa concept in a duty-free store, The Shilla Duty Free Singapore continually elevates the travel retail experience by offering shoppers exclusive and differentiated services that resonate with travellers. As an affiliate company of Samsung, The Shilla Duty Free is a leading travel retailer offering over 1,300 world-famous brands in fashion, jewellery, cosmetics, perfumes, watches, etc. In Korea, the travel retailer currently operates 4 duty free outlets- two in downtown Seoul and Jeju and two in Incheon Airport. With the initiation of the Hong Kong International Airport PC/FA operation, The Shilla Duty Free has become the first travel retailer to operate the Cosmetics & Perfumes category in three major hub airports in East Asia (Incheon, Changi, and Hong Kong).
2026-02-02 05:56:00

0.059468984603882


消息
消息
也门
消息
也门
消息